San Donato Milanese, Italy

Marco Ferrara

USPTO Granted Patents = 27 


 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Pomezia, IT (2012)
  • Rome, IT (2015)
  • San Donato, IT (2016 - 2020)
  • Sam Donato Milanese, IT (2020)
  • San Donato Milanese, IT (2014 - 2023)
  • Ingelheim am Rhein, DE (2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: Marco Ferrara: Innovator in Pharmaceutical Patents

Introduction

Marco Ferrara, a prolific inventor located in San Donato Milanese, Italy, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 26 patents. His innovations primarily focus on compounds that play a crucial role in treating various central nervous system diseases.

Latest Patents

Ferrara's cutting-edge inventions include:

1. **3-Phenoxyazetidin-1-yl-Heteroaryl Pyrrolidine Derivatives**: This invention pertains to novel compounds that act as agonists of the GPR52 receptor, which are useful in treating central nervous system diseases among others. It also encompasses pharmaceutical compositions that contain these compounds and processes for their preparation.

2. **Substituted 3-Phenoxyazetidin-1-yl-Pyrazines**: Similar to his previous work, this patent addresses compounds that are agonists of GPR52, intended for use in treating central nervous system diseases. This invention also details the formulation of pharmaceutical compositions incorporating these compounds alongside their manufacturing processes.

Career Highlights

Marco Ferrara has built an impressive career, contributing to renowned organizations such as Boehringer Ingelheim International GmbH and Centrexion Therapeutics Corporation. His dedication to innovation has positioned him as a thought leader in the pharmaceutical patent space.

Collaborations

Throughout his career, Ferrara has collaborated with notable colleagues, including Riccardo Giovannini and Niklas Heine. These collaborations have further enriched his patent portfolio and broadened his impact within the industry.

Conclusion

Marco Ferrara's inventive work and extensive patent portfolio exemplify his commitment to advancing pharmaceutical science. His contributions are not only valuable in treating diseases but also represent significant milestones in patent innovation, underscoring the importance of intellectual property in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…